Patents Assigned to IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
  • Recombinant Human Papillomavirus Vaccine Composition and Use thereof
    Publication number: 20230000968
    Abstract: Disclosed in the present disclosure are a recombinant human papillomavirus vaccine composition and a use thereof. Compared with other combinations of antigens and adjuvants, the new vaccine composition provided in the present invention has a more beneficial immune effect.
    Type: Application
    Filed: June 24, 2020
    Publication date: January 5, 2023
    Applicant: IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
    Inventors: Li SHI, Zhi ZHANG, Wenli TIAN, Weiliang XUE, Xiaodong SUN, Wei YANG, Wei LI
  • Recombinant Herpes Zoster Vaccine Composition and Application Thereof
    Publication number: 20220347293
    Abstract: Disclosed in the present invention are a recombinant herpes zoster vaccine composition and an application thereof. Compared with other combinations of antigens and adjuvants, the novel vaccine composition provided by the present invention has a more beneficial immune effect.
    Type: Application
    Filed: June 24, 2020
    Publication date: November 3, 2022
    Applicant: IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
    Inventors: Li SHI, Zhi ZHANG, Wenli TIAN, Lin LIU, Xiaodong SUN, Wei YANG, Wei LI
  • COMPOSITE ADJUVANT SYSTEM AND METHOD FOR PREPARING ADJUVANT
    Publication number: 20220331424
    Abstract: Present disclosure is a new adjuvant system containing an aluminum phosphate adjuvant and a CpG adjuvant and the preparation method thereof.
    Type: Application
    Filed: June 24, 2020
    Publication date: October 20, 2022
    Applicant: IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
    Inventors: Li SHI, Zhi ZHANG, Wenli TIAN, Zhihao LI, Chengren SHEN